LBX Pharmacy Chain JSC banner

LBX Pharmacy Chain JSC
SSE:603883

Watchlist Manager
LBX Pharmacy Chain JSC Logo
LBX Pharmacy Chain JSC
SSE:603883
Watchlist
Price: 13.5 CNY 1.12% Market Closed
Market Cap: ¥10.2B

LBX Pharmacy Chain JSC
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

LBX Pharmacy Chain JSC
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
LBX Pharmacy Chain JSC
SSE:603883
Note Receivable
¥61m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
11%
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LBX Pharmacy Chain JSC
Glance View

Market Cap
10.2B CNY
Industry
Retail

LBX Pharmacy Chain JSC has emerged as a significant player in the pharmaceutical retail sector in China, riding the wave of increasing health consciousness and the aging population. Founded in a fast-paced, constantly evolving market, the company has strategically positioned itself to leverage this demographic shift. Its primary business model revolves around operating an extensive network of pharmacy outlets that serve both urban and rural customers. By offering a wide range of products, from prescription medications to health supplements and wellness goods, LBX ensures it caters to a diverse clientele, satisfying varying health care needs. The implementation of an omnichannel approach, integrating online and offline sales, has not only enhanced customer convenience but also expanded its reach, reinforcing its market position. Central to LBX’s profitability is its efficient supply chain management and strategic location of stores in high-traffic areas, which augments its accessibility and stock management capabilities. The company leverages partnerships with leading pharmaceutical manufacturers and distributors, securing competitive pricing and product availability. Additionally, its investment in technology bolsters its operational efficiency, enabling real-time inventory tracking and personalized customer service. This tech-driven approach enhances customer loyalty and provides insights into consumer behavior, guiding strategic decisions. Through a well-crafted blend of traditional retail expertise and innovative solutions, LBX Pharmacy Chain JSC continues to solidify its foothold in the market, driving revenue growth and expanding its reach across China.

Intrinsic Value
28.71 CNY
Undervaluation 53%
Intrinsic Value
Price

See Also

What is LBX Pharmacy Chain JSC's Note Receivable?
Note Receivable
61m CNY

Based on the financial report for Sep 30, 2025, LBX Pharmacy Chain JSC's Note Receivable amounts to 61m CNY.

What is LBX Pharmacy Chain JSC's Note Receivable growth rate?
Note Receivable CAGR 10Y
11%

Over the last year, the Note Receivable growth was -31%. The average annual Note Receivable growth rates for LBX Pharmacy Chain JSC have been -7% over the past three years , -2% over the past five years , and 11% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett